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Purpose or Objective  
Radiotherapy of bladder carcinoma requires substantial 
CTV-PTV margins to account for day-to-day bladder 
volume variations. A method to reduce these margins, and 
hence organs at risk (OAR) dose, is the Plan of the Day 
method (PotD).  
In preparation of a PotD approach, we introduced an 
offline adaptive radiotherapy (ART) procedure based on 
ConeBeam CT (CBCT) analysis to select individualized 
adequate margins for the bladder. Tight PTV margins were 
defined on a retrospective CBCT analysis (N=9, 56 CBCTs) 
(table 1).  
 
Table 1: CTV-PTV margins for initial plan (wide) and 
adaptive (ART) plan (tight) 
Material and Methods  
Pretreatment MRI scans with variable bladder filling were 
acquired to determine the GTV and the empty, medium 
and fully filled bladder structure (CTV). During the 
pretreatment CT planning the bladder was filled according 
to the medium filled MRI protocol (± 200 mL).  
All patients were treated with a Volumetric Modulated Arc 
Therapy (VMAT) Simultaneous Integrated Boost (SIB) 
technique. The prescribed dose was 46 Gy (2 Gy per 
fraction) to the bladder and 59.8 Gy (2.6 Gy per fraction) 
to  the  GTV.  
Patients were instructed to perform a comfortably filled 
(± 200 mL) bladder during treatment. Before each 
treatment session a CBCT was obtained and a manual soft 
tissue match was performed on the bladder volume. When 
the PTV did not cover the bladder volume correctly, 
patients were asked to void their bladder or drink water. 
The GTV location was decisive for the match. A 
subsequent 3D online translation correction was applied.  
The initial 3 treatment fractions were delivered with a 
plan based on the medium filled bladder with wide PTV 
margins (table 1). After 3 fractions it was decided if an 
ART plan could be used. The best fitting CTV (empty, 
medium or full) (figure 1) and PTV (wide or tight) margins 
were chosen. The ART plan was delivered from fraction 6 
to 23. Daily online CBCT position verification was still 
performed to monitor adequate bladder coverage by the 
PTV. 
 
 
Figure 1: CBCT image of the initial plan. CTV medium 
bladder filling fits well on CBCT bladder.  
Results  
5 patients were treated with our simple ART method since 
June 2016. For 3 patients the medium bladder filling with 
tight PTV margins were used. The mean PTV was 28% 
smaller for the adaptive plans compared to the initial 
plans.  
The other 2 patients were treated with a medium bladder 
filling and wide PTV margins during the whole treatment. 
One of these patients could, in retrospect, have been 
treated with tight margins because the bladder filling 
became smaller after fraction 3. The other patient showed 
deformation of the bladder, and the treatment had to be 
continued with wide PTV margins. 
Conclusion  
A simple ART workflow was introduced for bladder 
carcinoma. By offline selection of a plan based on the 
most representative treatment bladder volume, tight PTV 
margins could be applied and OAR doses were thus 
reduced. Daily verification of the bladder filling is 
necessary to monitor the GTV and CTV coverage. This 
approach to ART in bladder carcinoma is a safe and simple 
method to reduce PTV margins. 
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Purpose or Objective  
To assess the effect of intra-fractional bladder filling on 
adaptive bladder radiotherapy and investigate if the 
current departmental adaptive bladder treatment 
planning margins and plan selection options are 
appropriate. 
Material and Methods  
A retrospective audit was carried out on 38 pairs of pre-
treatment and post-treatment cone beam computed 
tomography scans (CBCTs) from 20 adaptive bladder 
radiotherapy patients. The bladder was contoured on both 
pre and post-treatment CBCTs to quantitatively analyse 
the differences in bladder volume and bladder wall 
expansion over the treatment fraction. Treatment time 
was established from acquisition of pre-treatment CBCT to 
acquisition of post-treatment CBCT. A non-parametric 
Spearman’s Rank correlation test was conducted to 
investigate if there was a relationship between intra-
fractional bladder filling and treatment time. 
Results  
A variety of intra-fractional bladder filling and intra-
fractional bladder wall expansions were observed. Mean 
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intra-fractional filling volume was 10.2cm3 (standard 
deviation (SD) = 7.1cm3; range= 0.3-26.9cm3). Average 
treatment time was 8.9 minutes (SD = 1.8mins; range= 6.5-
13.6mins). Intra-fractional bladder filling resulted in 
expansion of the bladder predominately in the superior 
and anterior directions with mean translations 2.5mm 
(SD=1.9mm; range= 0-6mm) and 1.5mm (SD=1.4mm; 
range= 0-5mm) respectively.  
As expected, an increase intra-fractional bladder filling 
was associated with an increase overall treatment time (rs 
= 0.323, p = 0.048). All plan selection options chosen 
adequately covered the bladder target treatment volume.  
Conclusion  
Despite the effect of intra-fractional bladder filling, it’s 
suggested that current use of the adaptive bladder 
treatment planning margins and decision making for all 
plan selections sufficed. All treatments were delivered 
within an appropriate time frame for the local hospital 
department. Due to the limited expansion of the bladder 
wall laterally, consider reducing the lateral margin 
requirement if a more conformal plan could be selected 
whilst minimising dose to the surrounding normal tissue. 
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Purpose or Objective  
Gating function has been available in our hospital for the 
proton therapy system since March, 2016. Gating signals 
generated by a respiratory gating system control the 
output of proton beam. However, there is latency 
between gating control signal and proton beam 
emission/interception and a long latency would affect the 
treatment accuracy. We verified the latency periods and 
report the results here. 
Material and Methods  
A globally used respiratory gating system Abches was used 
for gating signal control.  A motion phantom was used for 
respiratory motion simulation with two modes of motion 
phantom respiratory speed: 3 sec/fraction and 6 
sec/fraction. Gating function was enabled by the Wobbler 
method in the proton therapy system. The latency 
between the start of gating signal emission and the start 
of proton beam generation, and that between the end of 
gating signal emission and the interception of the proton 
beam were measured. 
Results  
With the motion speed at 3 sec/fraction, the mean latency 
at the start of signal emission was 61.75±20.55 msec and 
at the end of gating signal was 41.4  ± 30.69 msec. With 
the motion speed at 6 sec/fraction, the mean latency at 
the start of signal emission was 36.7±27.24 msec and at 
the end of gating signal was 46.8±28.73 msec.) 
Conclusion  
The results of gating latency between our proton therapy 
system and the respiratory gating system Abches in this 
study satisfied the AAPM-TG142 recommended criteria of 
100 msec, proving the applicability of the systems. 
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Purpose or Objective  
In external beam radiotherapy of the uterine cervix, large 
day-to-day movements of the cervix can be seen that are 
associated with changes in rectum and bladder filling. 
These movements should be taken into account in 
treatment planning, by delineation of an internal target 
volume (ITV), a careful choice of safety margins, or daily 
plan selection based on the position of the uterus. In this 
study, the motion of the uterine cervix was monitored 
using implanted polymer markers visualized by CBCT. The 
correlation of this motion to bladder and rectum filling 
was estimated, and treatment margins were calculated. 
Material and Methods  
234 CBCT images of 10 patients with implanted markers 
were included. Interfraction motion of the cervix was 
studied by determining the 3D vector between the center 
of the markers on CBCT and (full-bladder) planning CT. An 
inter-observer variability study was determined for this 
analysis. The correlation between cervix and bladder 
dimensions and rectum diameter was studied. CTV-PTV 
margins were calculated using the Van Herk recipe. 
Results  
A strong and statistically significant correlation of cervix 
motion in the AP direction was found with the rectum 
diameter (Pearson correlation coefficient r = 0.82 (p < 
0.001)). Correlation with the bladder dimensions in this 
study was found significant however weak for the AP and 
SI directions (-0.29  and -0.28 (p < 0.001), respectively). 
Motion of the cervix was largest in the AP and SI directions 
(Mean (SD of means): 4.1 (11.5) and 5.0 (5.6), 
respectively) The calculated margins equal 8.7, 33.0 and 
18.0 mm in the LR/AP/SI directions. 
Conclusion  
Correlation with bladder and rectum filling, and preferred 
direction of motion, were shown comparable to previous 
studies. Calculated CTV-PTV margins were larger than 
those used in clinical practice. These can be decreased 
when an ITV is delineated based on multiple CT/MR images 
with varying bladder/rectum filling, or when a plan-of-
the-day approach is  used. 
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Purpose or Objective  
Adaptive plan of the day (PoD) for cervical cancer has 
recently been implemented at our centre. PoD using daily 
CBCT reduces the risk of geometric miss by actively 
choosing a suitable plan based on a variable CTV position 
and has the potential of reducing toxicity to organs at risk 
(OARs). This planning study aimed to assess the potential 
benefits by recalculating the plan on the daily CBCT 
datasets, comparing changes to CTV and OAR dose as 
treatment progressed.  
Material and Methods  
All patients treated with this technique had planning CTs 
acquired with empty and full bladder and a MRI with mid-
bladder filling. Multiple CTVs were outlined on each of the 
datasets to include uterus and proximal vagina, from 
which ITVs and PTVs were defined with further nodal 
volumes as required. VMAT plans were created for each 
PTV. Online daily CBCT was performed for all patients over 
the course of 25 treatments and the appropriate PoD was 
chosen based on the position of the CTV. 
The cervix CTV, rectum, bladder and bowel organs were 
contoured on all CBCTs. Initially the chosen PoD treatment 
